Search

everythinglearnresearchcommunity

for

Search:↓

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

PRC2 is essential for maintaining intestinal cell balance and aiding regeneration after damage.

UV light helped human hair transplants survive in mice without broad immunosuppression.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

A cancer patient's hair became permanently curly after treatment with nivolumab.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Certain immune system genes are linked to a higher risk of psoriasis and psoriatic arthritis, while others may offer protection.

Tislelizumab can cause cutaneous lupus erythematosus.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Adult stem cells with Tp63 can form hair and skin cells when placed in new skin, showing they have hidden abilities for skin repair.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Stem cells help control the immune response to improve wound healing.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Pemphigus vulgaris involves specific immune cells and B cells that produce antibodies causing skin blisters.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.